Tracleer Litigation Settlement

What happened

The defendants allegedly unlawfully delayed the entry of generic formulations of bosentan into the market, causing third-party payors to pay more for brand Tracleer and bosentan than they should have. Defendants deny wrongdoing and there has been no court determination that the allegations were proven or caused harm.

Do you qualify?

The class consists of all entities that purchased, paid, or provided reimbursement for Tracleer or bosentan for their members, employees, insureds, participants, or beneficiaries (not for resale) in specified states including Arizona, California, Illinois, Florida, Maryland, New York, and others, between December 29, 2015, and September 6, 2024. Excluded are the defendants and their subsidiaries, and federal and state governmental entities.

Who is in the class

All entities that, for consumption by their members, employees, insureds, participants or beneficiaries, purchased, paid and/or provided reimbursement for some or all of the purchase price of Tracleer or bosentan, other than for resale, in Arizona, California, Florida, Illinois, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Rhode Island, South Carolina, South Dakota, Utah, Vermont, Virginia, West Virginia, Wisconsin, the District of Columbia, or Puerto Rico, at any time during the period from December 29, 2015, through and until September 6, 2024.

Quoted from the settlement notice.

How to file

Submit a claim form online or by mail by August 3, 2026. You can submit a claim if you are a member of the class and purchased or paid for Tracleer or bosentan during the specified period.